Inhibitory effects of saikosaponin-d on CCl4-induced hepatic fibrogenesis in rats

被引:0
|
作者
Shuang-Suo Dang
机构
基金
中国国家自然科学基金;
关键词
Saikosaponin-d; Hepatic fibrosis; Tumor necrosis factor; Interleukins-6; Nuclear factor-κB; Inhibitory κB alpha;
D O I
暂无
中图分类号
R575.2 [肝硬变];
学科分类号
1002 ; 100201 ;
摘要
AIM: To investigate the suppressive effect of saikosaponin-d (SSd) on hepatic fibrosis in rats induced by CCl4 injections in combination with alcohol and high fat, low protein feeding and its relationship with the expression of nuclear factor-κB (NF-κB), tumor necrosis factor-alpha (TNF-α) and interleukins-6 (IL-6). METHODS: Hepatic fibrosis models were induced by subcutaneous injection of CCl4 at a dosage of 3 mL/kg in rats. At the same time, rats in treatment groups were injected intraperitoneally with SSd at different doses (1.0, 1.5 and 2.0 mg/kg) once daily for 6 wk in combination with CCl4, while the control group received olive oil instead of CCl4. At the end of the experiment, rats were anesthetized and killed (except for 8 rats which died during the experiment; 2 from the model group, 3 in high-dose group, 1 in medium-dose group and 2 in low- dose group). Hematoxylin and eosin (HE) staining and Van Gieson staining were used to examine the changes in liver pathology. The levels of alanine aminotransferase (ALT), triglyeride (TG), albumin (ALB), globulin (GLB), hyaluronic acid (HA) and laminin (LN) in serum and the content of hydroxyproline (HYP) in liver were measured by biochemical examinations and radioimmuneoassay, respectively. In addition, the expression of TNF-α and IL-6 in liver homogenate was evaluated by enzyme- linked immunosorbent assay (ELISA) and the levels of NF-κBp65 and I-κBα in liver tissue were analyzed by Western blotting. RESULTS: Both histological examination and Van Gieson staining demonstrated that SSd could attenuate the area and extent of necrosis and reduce the scores of liver fibrosis. Similarly, the levels of ALT, TG, GLB, HA, andLN in serum, and the contents of HYP, TNF-α and IL-6 in liver were all significantly increased in model group in comparison with those in control group. Whereas, the treatment with SSd markedly reduced all the above parameters compared with the model group, especially in the medium group (ALT: 412 ± 94.5 IU/L vs 113.76 ± 14.91 IU/L, TG: 0.95 ± 0.16 mmol/L vs 0.51 ± 0.06 mmol/L, GLB: 35.62 ± 3.28 g/L vs 24.82 ± 2.73 g/L, HA: 42.15 ± 8.25 ng/mL vs 19.83 ± 3.12 ng/mL, LN: 27.56 ± 4.21 ng/mL vs 13.78 ± 2.57 ng/mL, HYP: 27.32 ± 4.32 μg/mg vs 16.20 ± 3.12 μg/mg, TNF-α: 4.38 ± 0.76 ng/L vs 1.94 ± 0.27 ng/L, IL-6: 28.24 ± 6.37 pg/g vs 12.72 ± 5.26 pg/g, respectively, P < 0.01). SSd also decreased ALB in serum (28.49 ± 4.93 g/L vs 37.51 ± 3.17 g/L, P < 0.05). Moreover, the expression of NF-κB p65 in the liver of treated groups was lower than that in model groups while the expression of I-κBα was higher in treated group than in model group (P < 0.01). The expression of NF-κBp65 and TNF-α had a positive correlation with the level of HA in serum of rats after treatment with CCl4 (r = 0.862, P < 0.01; r = 0.928, P < 0.01, respectively). CONCLUSION: SSd attenuates CCl4-induced hepatic fibrosis in rats, which may be related to its effects of hepato-protective and anti-inflammation properties, the down-regulation of liver TNF-α, IL-6 and NF-κBp65 expression and the increased I-κBα activity in liver.
引用
收藏
页码:557 / 563
页数:7
相关论文
共 50 条
  • [21] EFFECTS OF SAIKOSAPONIN-D ON THE FUNCTIONS AND MORPHOLOGY OF MACROPHAGES
    USHIO, Y
    ABE, H
    INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1991, 13 (05): : 493 - 499
  • [22] Haematopoietic induction and hepatic protective roles of Hepacare® in CCl4-induced hepatic damaged rats
    Adebayo A.H.
    Yakubu O.F.
    Adegbite O.S.
    Okubena O.
    Comparative Clinical Pathology, 2017, 26 (3) : 679 - 688
  • [23] Inhibitory effects of a targeted inhibitor of tyrosine kinase phosphorylation on CCl4-induced hepatic fibrosis and on hepatic stellate cell proliferation.
    Zhu, JL
    Wu, J
    Zern, MA
    HEPATOLOGY, 1999, 30 (04) : 487A - 487A
  • [24] Hepatoprotective activity of Beta vulgaris against CCl4-induced hepatic injury in rats
    Agarwal, A
    Srivastava, VK
    Saxena, KK
    Kumar, A
    FITOTERAPIA, 2006, 77 (02) : 91 - 93
  • [25] The protective effect of HD-03 in CCl4-induced hepatic encephalopathy in rats
    Mitra, SK
    Venkataranganna, MV
    Gopumadhavan, S
    Anturlikar, SD
    Seshadri, SJ
    Udupa, UV
    PHYTOTHERAPY RESEARCH, 2001, 15 (06) : 493 - 496
  • [26] A New Oleanolic Acid Derivative against CCl4-Induced Hepatic Fibrosis in Rats
    Xiang, Hongjun
    Han, Yaotian
    Zhang, Yuzhong
    Yan, Wenqiang
    Xu, Bing
    Chu, Fuhao
    Xie, Tianxin
    Jia, Menglu
    Yan, Mengmeng
    Zhao, Rui
    Wang, Penglong
    Lei, Haimin
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (03):
  • [27] Protective effect of Enicostemma littorale against CCl4-induced hepatic damage in rats
    Senthilkumar, KTM
    Rajkapoor, B
    Kavimani, S
    PHARMACEUTICAL BIOLOGY, 2005, 43 (05) : 485 - 487
  • [28] Therapeutic effect of interleukin-10 on CCl4-induced hepatic fibrosis in rats
    Yue-Hong Huang
    Mei-Na Shi
    Wei-Da Zheng
    Li-Juan Zhang
    Zhi-Xin Chen
    Xiao-Zhong Wang
    WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (09) : 1386 - 1391
  • [29] Hepatoprotection by Freshwater Clam Extract Against CCl4-Induced Hepatic Damage in Rats
    Hsu, Chin-Lin
    Hsu, Chien-Chen
    Yen, Gow-Chin
    AMERICAN JOURNAL OF CHINESE MEDICINE, 2010, 38 (05): : 881 - 894
  • [30] SPECIFICITY OF THE THIOBARBITURIC ACID DETERMINATION IN CCL4-INDUCED HEPATIC-INJURY IN RATS
    CABRE, M
    JOVEN, J
    CAMPS, J
    MEDICAL SCIENCE RESEARCH, 1993, 21 (02): : 55 - 57